Squarepoint Ops LLC Mustang Bio, Inc. Transaction History

Squarepoint Ops LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.58 - $3.36 $47,786 - $62,233	-18,522 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$2.7 - $3.81 $50,009 - $70,568	18,522 New	18,522 $61,000
Q1 2021 May 17, 2021	SELL	$3.02 - $5.16 $766,705 - $1.31 Million	-253,876 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$2.66 - $4.18 $363,074 - $570,544	136,494 Added 116.28%	253,876 $961,000
Q3 2020 Nov 16, 2020	BUY	$3.01 - $3.88 $198,377 - $255,715	65,906 Added 128.03%	117,382 $370,000
Q2 2020 Aug 14, 2020	SELL	$2.33 - $4.6 $44,812 - $88,471	-19,233 Reduced 27.2%	51,476 $164,000
Q1 2020 May 15, 2020	BUY	$1.91 - $4.52 $135,054 - $319,604	70,709 New	70,709 $190,000
Q3 2018 Nov 14, 2018	SELL	$5.71 - $7.58 $67,378 - $89,444	-11,800 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$6.68 - $11.0 $78,824 - $129,800	11,800 New	11,800 $81,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $22.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.